PEOPLE - CR Bard makes appointment:
This article was originally published in Clinica
Vascular, urology and oncology technology developer CR Bard (Murray Hill, New Jersey) has elected Gail Naughton to its board of directors. Ms Naughton serves for San Diego State University, and prior to this, served for over 15 years at Advanced Tissue Sciences, where she was the company's co-founder and co-inventor of its core technology. She also held executive roles such as president, COO, chief scientific officer and principal scientist.
You may also be interested in...
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.
Theradaptive's “paint-like” regenerative therapeutic can be applied to any device to promote bone regrowth or regenerate tissue.